Molecular considerations for development of phage antibody libraries.
about
Computerized techniques pave the way for drug-drug interaction prediction and interpretationBacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infectionRadiolabeled theranostics: magnetic and gold nanoparticlesCombinatorial approaches for the identification of brain drug delivery targets.Diversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display librarySelection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy.Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotidesThe delivery of therapeutic oligonucleotidesCellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.Back to the future: bacteriophages as promising therapeutic tools.Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapyA prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination.New human single chain anti-idiotypic antibody against benzo[a]pyrene.Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes.Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.
P2860
Q26741470-310916B3-579D-47D6-83DA-76DF0D5B4CC6Q26822719-FFF1B6A7-863D-454D-84A5-8C7ACABAE56DQ28074696-136C2E76-5984-441A-824C-E739DD764D1DQ31119779-2E5543C5-6F89-44A1-A9D5-AFE59F2F56F2Q34276746-5AB059AC-1B6D-46CC-A231-C930BE88E1E2Q34560363-7587250C-5131-41D9-8AE3-EF5C264BD97CQ35419158-C0BB7344-E6E0-4613-ADA9-8E2957DA2A5EQ37015817-23EB5FE2-0206-4A57-ACE6-6B1813F763A4Q37210936-851FB65D-E9F2-4B36-AAD6-49688011BE3AQ37656119-913561D9-A2ED-49BD-A0B3-C4E08E624CB0Q38739669-5661103C-E5C9-4271-BFBD-B82EB86E7528Q39331773-1B4A9865-337D-4664-AE26-89270E2F1F27Q41143135-FDD7D694-F54E-41F7-A6C5-93E6AC0C4E86Q41539697-462780A3-B668-4293-9EC3-28D906E0C25CQ43376027-C9843228-2CA9-49E6-8978-34F3C8DE0AABQ48159250-1A47F052-FF09-448A-A10C-233BE685DFEF
P2860
Molecular considerations for development of phage antibody libraries.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular considerations for development of phage antibody libraries.
@ast
Molecular considerations for development of phage antibody libraries.
@en
Molecular considerations for development of phage antibody libraries.
@nl
type
label
Molecular considerations for development of phage antibody libraries.
@ast
Molecular considerations for development of phage antibody libraries.
@en
Molecular considerations for development of phage antibody libraries.
@nl
prefLabel
Molecular considerations for development of phage antibody libraries.
@ast
Molecular considerations for development of phage antibody libraries.
@en
Molecular considerations for development of phage antibody libraries.
@nl
P2860
P50
P1476
Molecular considerations for development of phage antibody libraries
@en
P2093
Farzad Asadi
P2860
P304
P356
10.3109/1061186X.2011.611517
P577
2011-09-27T00:00:00Z